Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Journal of Affective Disorders|June 10, 2018
Suicide death rates in patients with cardiovascular diseases - A 15-year nationwide cohort study in TaiwanVictor Chien-Chia Wu, Shang-Hung Chang, Chang-Fu Kuo, et al.
International Journal of Cardiology|April 28, 2015
Simvastatin-ezetimibe combination therapy is associated with a lower rate of major adverse cardiac events in type 2 diabetics than high potency statins alone: A population-based dynamic cohort studyShang-Hung Chang, Lung-Sheng Wu, Cheng-Hung Lee, et al.
Medicine|July 13, 2017
Metformin is associated with fewer major adverse cardiac events among patients with a new diagnosis of type 2 diabetes mellitus: A propensity score-matched nationwide studyKuang-Tso Lee, Yung-Hsin Yeh, Shang-Hung Chang, et al.
JAMA Network Open|September 1, 2020
Type of Androgen Deprivation Therapy and Risk of Dementia Among Patients With Prostate Cancer in TaiwanWen-Kuan Huang, Chi-Hung Liu, See-Tong Pang, et al.
Cardiovascular Diabetology|August 10, 2014
Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studiesShang-Hung Chang, Lung-Sheng Wu, Meng-Jiun Chiou, et al.
Internal Medicine Journal|May 30, 2018
End-stage renal disease patients using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may reduce the risk of mortality: a Taiwanese Nationwide cohort studyHsin-Fu Lee, Lai-Chu See, Yi-Hsin Chan, et al.
Digestive Diseases and Sciences|April 4, 2015
The Trend of Inflammatory Bowel Diseases in Taiwan: A Population-Based StudyChia-Jung Kuo, Kuang-Hui Yu, Lai-Chu See, et al.
Cardiovascular Diabetology|October 1, 2020
Major adverse cardiovascular and limb events in patients with diabetes and concomitant peripheral artery disease treated with sodium glucose cotransporter 2 inhibitor versus dipeptidyl peptidase-4 inhibitorHsin-Fu Lee, Shao-Wei Chen, Jia-Rou Liu, et al.
Cardiovascular Diabetology|December 21, 2017
Dipeptidyl peptidase-4 inhibitor decreases the risk of atrial fibrillation in patients with type 2 diabetes: a nationwide cohort study in TaiwanChia-Yu Chang, Yung-Hsin Yeh, Yi-Hsin Chan, et al.
The Journal of Clinical Endocrinology and Metabolism|February 4, 2020
Direct Oral Anticoagulants in Atrial Fibrillation Patients With Concomitant HyperthyroidismYi-Hsin Chan, Lung-Sheng Wu, Lai-Chu See, et al.
Pageof 6